文档介绍：·132· 第 37 卷第 1 期 2022 年 1 月 现代药物与临床 Drugs & Clinic Vol. 37 No. 1 January 2022
复方万gzhou
450052, China
2. Zhengzhou Jianzhong Street Community Health Service Center, Zhengzhou 450000, China
3. Department of Digestive and Gastroenterology, Henan Corps Hospital of the Chinese People’s Armed Police Force, Zhengzhou
450052, China
4. No. 2 Department of Gastroenterology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
Abstract: Objective To observe the clinical efficacy of Compound Wannianqing Capsules combined with SOX chemotherapy
regimen in treatment of advanced gastric cancer. Methods Patients (107 cases) with advanced gastric cancer in Henan Corps Hospital
of the Chinese People’s Armed Police Force from March 2018 to February 2021 were randomly divided into the control group (53
cases) and the treatment group (54 cases). Patients in the control group were given SOX chemotherapy regimen. Patients in the control
group were iv administered with Oxaliplatin for injection at the first day, 130 mg/(m2·d) added into 10% glucose injection 500 mL,
intravenous drip for 3 h, once every 21 d. Meanwhile patients in the control group were po administered with Tegafur, Gimeracil and
Oteracil Potassium Capsules, twice daily, continuous treatment for 14 d, a